Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiuwei Qingzhi Ointment is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine for the treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The name 'Jiuwei' (nine flavors) indicates that the formulation is composed of nine herbal ingredients. In TCM theory, the ointment is designed to strengthen the spleen, clear heat, promote diuresis, and remove turbidity, addressing the metabolic imbalances and 'damp-heat' patterns associated with fatty liver conditions. It is typically prepared as an internal paste (Gao Fang), a concentrated herbal form used for the management of chronic metabolic disorders. The formulation is currently being evaluated in clinical trials to assess its efficacy in reducing hepatic fat and improving liver function in patients with NASH.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiuwei qingzhi.